The Mammography Quality Standards Act Final Regulations Document #2

Dec 1, 1999
1498.pdf
Latest in Regulatory
Finger pressing green keyboard key labeled FDA Food and Drug Administration
Recalls stable for radiation oncology tools despite tech advancements
September 18, 2026
Finger pressing green keyboard key labeled FDA Food and Drug Administration
FDA issues discussion paper on GenAI medical devices
August 18, 2026
Blue approved stamp seal with distressed circular design and white text
Lantheus wins FDA approval for tau PET imaging agent
August 14, 2026
Modern MRI scanner in hospital room with blue lighting and control panel
Petition asks FDA to implement new OEM rule for MRI safety
July 14, 2026
Related Stories
Green Pix
Regulatory
Quality Mammography Standards - Delay of Effective Date
More in Regulatory
Recalls stable for radiation oncology tools despite tech advancements
By Amerigo Allegretto
While radiation oncology devices using AI or machine learning are increasingly entering the market, recalls may be plateauing.
September 18, 2026
Finger pressing green keyboard key labeled FDA Food and Drug Administration
FDA issues discussion paper on GenAI medical devices
By AuntMinnie.com staff writers
The paper covers risk assessment, pre-market evaluation, and considerations around foundation models and agentic AI systems.
August 18, 2026
Finger pressing green keyboard key labeled FDA Food and Drug Administration
Lantheus wins FDA approval for tau PET imaging agent
By AuntMinnie.com staff writers
Tauklarify, previously known as MK-6240, has been approved for tau PET imaging in adults with cognitive impairment being evaluated for Alzheimer's disease.
August 14, 2026
Blue approved stamp seal with distressed circular design and white text
Petition asks FDA to implement new OEM rule for MRI safety
By Liz Carey
Radiofrequency (RF)-induced burns prompt recommendations to MRI manufacturers.
July 14, 2026
Modern MRI scanner in hospital room with blue lighting and control panel
RadioMedix wins FDA ANDA approval for Ga-68 PSMA-11 PET imaging agent
By AuntMinnie.com staff writers
Company highlights ANDA and FDA inspection.
June 10, 2026
Glowing atom symbol in a laboratory setting with test tubes and scientific equipment
Radiopharmaceutical manufacturers report uneven FDA inspections
By Liz Carey
RMTA lays out radiopharmaceutical regulatory and payment policy issues.
June 4, 2026
Modern laboratory facility with white equipment, workstations, and two technicians in lab coats operating scientific instruments
MGMA endorses bill promising Medicare Advantage (MA) reform
By AuntMinnie.com staff writers
MA is becoming untenable for many practices, according to MGMA.
April 24, 2026
American flag flying in front of the U.S. Capitol Building dome under a dramatic cloudy sky
CMS, FDA align with new breakthrough medical device coverage pathway
By AuntMinnie.com staff writers
CMS will pause Transitional Coverage for Emerging Technologies (TCET).
April 24, 2026
White card with 'POLICY UPDATE' text pinned to gray surface with yellow pushpin
FDA strikes down radiology AI 510(k) exemption arguments
By Liz Carey
Regulator rejects broad statement of user capabilities in detecting performance issues.
April 13, 2026
Digital regulation concept with cyan circular interface surrounded by hexagonal icons for user, search, target, and settings on tech background
FDA accepts Telix NDA for glioma PET agent Pixclara
By AuntMinnie.com staff writers
The NDA resubmission included additional data and statistical analysis requested by the U.S. FDA.
April 10, 2026
Multiple MRI brain scans showing axial cross-sections with blue anatomical detail and orange activation areas indicating neural activity
Bayer gets first approval for gadoquatrane in Japan
By AuntMinnie.com staff writers
Bayer received approval from Japan's Ministry of Health, Labour, and Welfare for its low-dose macrocyclic gadolinium-based contrast agent gadoquatrane.
March 24, 2026
Bayer logo featuring dark teal text arranged in a cross pattern within a circular border of lime green and cyan blue
Telix resubmits NDA for Pixclara brain cancer PET imaging agent
By AuntMinnie.com staff writers
The New Drug Application (NDA) resubmission includes additional data and statistical analysis requested by the U.S. FDA.
March 17, 2026
Medical brain MRI scans with functional activation mapping shown in orange and yellow heat zones
Page 1 of 305
Next Page